Total Payments
$4,624
2024 Payments
$652.05
Companies
21
Transactions
136
Medicare Patients
5,002
Medicare Billing
$388,062
Payment Breakdown by Category
Food & Beverage$4,429 (95.8%)
Education$194.98 (4.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,429 | 134 | 95.8% |
| Education | $194.98 | 2 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,934 | 60 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $373.73 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $322.21 | 12 | $0 (2024) |
| Genentech USA, Inc. | $258.55 | 3 | $0 (2021) |
| Incyte Corporation | $257.91 | 5 | $0 (2023) |
| LEO Pharma Inc. | $198.78 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $188.16 | 9 | $0 (2021) |
| Dermavant Sciences, Inc. | $155.33 | 3 | $0 (2024) |
| Galderma Laboratories, L.P. | $122.55 | 1 | $0 (2019) |
| Helsinn Therapeutics (U.S.), Inc. | $109.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $652.05 | 23 | E.R. Squibb & Sons, L.L.C. ($322.21) |
| 2023 | $1,022 | 29 | ABBVIE INC. ($314.58) |
| 2022 | $827.82 | 22 | ABBVIE INC. ($703.98) |
| 2021 | $600.21 | 16 | AbbVie Inc. ($273.63) |
| 2020 | $405.88 | 17 | AbbVie Inc. ($150.66) |
| 2019 | $862.64 | 25 | AbbVie, Inc. ($433.35) |
| 2018 | $253.42 | 4 | Regeneron Healthcare Solutions, Inc. ($144.17) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Immunology | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: Immunology | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.24 | General |
| Category: Immunology | ||||||
| 09/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $100.20 | General |
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.07 | General |
| Category: Immunology | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: Immunology | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.23 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $91.80 | General |
| Category: Immunology | ||||||
| 05/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.56 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Immunology | ||||||
| 05/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: DERMATOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: DERMATOLOGY | ||||||
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Immunology | ||||||
| 01/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Inflammation | ||||||
| 01/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.95 | General |
| Category: DERMATOLOGY | ||||||
| 01/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Immunology | ||||||
| 01/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.45 | General |
| Category: Immunology | ||||||
| 10/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,144 | 4,133 | $827,455 | $174,368 |
| 2022 | 16 | 2,170 | 3,938 | $753,489 | $160,236 |
| 2021 | 10 | 688 | 1,069 | $225,385 | $53,459 |
Total Patients
5,002
Total Services
9,140
Medicare Billing
$388,062
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 378 | 592 | $222,832 | $49,312 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 277 | 317 | $95,092 | $20,149 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 215 | 215 | $105,377 | $19,613 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 349 | 461 | $91,362 | $16,761 | 18.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 102 | 138 | $68,890 | $15,987 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 230 | $61,154 | $12,460 | 20.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 255 | 1,716 | $33,834 | $8,148 | 24.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 91 | 99 | $32,747 | $7,507 | 22.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 42 | $30,371 | $6,875 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $35,593 | $6,697 | 18.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 84 | 150 | $22,303 | $5,476 | 24.6% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 28 | $14,202 | $2,833 | 19.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 13 | $6,850 | $1,379 | 20.1% |
| 69100 | Biopsy of ear | Office | 2023 | 23 | 24 | $6,849 | $1,171 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 250 | 333 | $126,154 | $29,185 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 210 | 210 | $103,881 | $21,022 | 20.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 276 | 320 | $97,219 | $20,498 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 226 | 258 | $69,158 | $15,791 | 22.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 325 | 406 | $80,753 | $13,770 | 17.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 163 | 181 | $60,729 | $13,437 | 22.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 85 | 108 | $53,943 | $12,122 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 167 | 167 | $55,330 | $10,545 | 19.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 255 | 1,631 | $32,538 | $7,618 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 104 | 173 | $26,230 | $6,409 | 24.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 32 | 38 | $27,585 | $5,687 | 20.6% |
About Dr. Kevin Nethers, M.D
Dr. Kevin Nethers, M.D is a Dermatology healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2017. The National Provider Identifier (NPI) number assigned to this provider is 1932631009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Nethers, M.D has received a total of $4,624 in payments from pharmaceutical and medical device companies, with $652.05 received in 2024. These payments were reported across 136 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,429).
As a Medicare-enrolled provider, Nethers has provided services to 5,002 Medicare beneficiaries, totaling 9,140 services with total Medicare billing of $388,062. Data is available for 3 years (2021–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Cary, NC
- Active Since 03/29/2017
- Last Updated 05/14/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1932631009
Products in Payments
- SKYRIZI (Biological) $944.59
- RINVOQ (Biological) $447.44
- DUPIXENT (Biological) $441.17
- Humira (Biological) $411.58
- Erivedge (Biological) $258.55
- Sotyktu (Drug) $222.01
- ADBRY (Biological) $198.78
- OPZELURA (Drug) $162.92
- VTAMA (Drug) $155.33
- DUPIXENT DUPILUMAB INJECTION (Biological) $144.17
- VALCHLOR (Drug) $109.25
- HUMIRA (Biological) $109.09
- VYVGART (Drug) $108.02
- TALTZ (Drug) $105.91
- Ilumya (Biological) $100.00
- CIBINQO (Drug) $83.78
- Otezla (Drug) $70.83
- Enbrel (Biological) $51.96
- Cimzia (Drug) $41.88
- DORYX (Drug) $32.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Cary
Craig Burkhart, M.d, M.D
Dermatology — Payments: $447,617
Dermatology $447,617
Dr. John Soderberg, M.d, M.D
Dermatology — Payments: $263,619
Dermatology $263,619
Mrs. Catherine Hren, M.d, M.D
Dermatology — Payments: $68,487
Dermatology $68,487
Timothy Flynn, M.d, M.D
Dermatology — Payments: $61,303
Dermatology $61,303
Mrs. Heidi Mangelsdorf, M.d, M.D
Dermatology — Payments: $15,039
Dermatology $15,039
Amy Gagnon, M.d, M.D
Dermatology — Payments: $6,254
Dermatology $6,254